Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Adenocarcinoma (non-small cell lung cancer) | 213 | 8 | |
Non-small cell lung cancer | 107 | 0 | |
Squamous cell carcinoma (non-small cell lung cancer) | 64 | 2 | |
Lung cancer | 53 | 1 | |
Adenosquamous carcinoma (non-small cell lung cancer) | 24 | 0 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Nerve pain (neuralgia) | 3 | |
Shortness of breath (dyspnea) | 3 | |
Shortness of breath with exertion | 2 | |
Breathing difficulty | 1 | |
Coughing when inhaling | 1 | |
Muscle spasms | 1 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 2 | |
Moderate | 4 | |
Mild | 2 | |
None | 5 |